BioCentury | Jun 18, 2020
Finance

June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

...up GMP manufacturing of the cytokine-armed oncolytic adenovirus DiogenX raises €4.5M Type I diabetes company DiogenX...
...financing, a series A round, in late 2021. BioCentury Staff Constellation Pharmaceuticals Celldex Therapeutics Inc. CureVac AG GreenLight Biosciences TILT Biotherapeutics Ltd. DiogenX...
Items per page:
1 - 1 of 1
BioCentury | Jun 18, 2020
Finance

June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

...up GMP manufacturing of the cytokine-armed oncolytic adenovirus DiogenX raises €4.5M Type I diabetes company DiogenX...
...financing, a series A round, in late 2021. BioCentury Staff Constellation Pharmaceuticals Celldex Therapeutics Inc. CureVac AG GreenLight Biosciences TILT Biotherapeutics Ltd. DiogenX...
Items per page:
1 - 1 of 1